Unknown

Dataset Information

Low Risk of Severe Complications After a Single, Post-Operative Instillation of Intravesical Chemotherapy in Patients with TaG1G2 Urothelial Bladder Carcinoma.


ABSTRACT:

Background

EAU guidelines recommend a single instillation (SI) of intravesical chemotherapy (e.g. Mitomycin C) within 24 hours after transurethral resection of a bladder tumour (TURBT) in patients with low- to intermediate risk non-muscle invasive bladder cancer without (suspected) bladder perforation or bleeding requiring bladder irrigation. However, remarkable variation exists in the use of SI. The risk of severe complications is likely to contribute to this variation, but evidence is limited.

Objective

To investigate the absolute severe complication and mortality risk after SI in low- and intermediate risk bladder cancer.

Methods

In this observational, historic cohort study, data on 25,567 patients diagnosed with TaG1G2 urothelial bladder carcinoma (UBC) between 20

SUBMITTER: van Hoogstraten LMC 

PROVIDER: S-EPMC11181802 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature